JP Morgan Chase
SKYE icon

JP Morgan Chase’s Skye Bioscience SKYE Stock Holding History

JP Morgan Chase’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39 Hold
66
– – ﹤0.01% 7374
2025
Q4 		$49 Buy
+66
New +$96 ﹤0.01% 7260
2025
Q2 		– Sell
-9,904
Closed -$15.7K – 7754
2025
Q1 		$15.7K Buy
9,904
+653
+7% +$1.78K ﹤0.01% 6212
2024
Q4 		$26.2K Sell
9,251
-2,111
-19% -$8.82K ﹤0.01% 6190
2024
Q3 		$44.4K Sell
11,362
-3,609
-24% -$20.2K ﹤0.01% 6032
2024
Q2 		$120K Buy
+14,971
New +$178K ﹤0.01% 5429

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

JP Morgan Chase's SKYE Position: Q1 2026 in Review

JP Morgan Chase held its Skye Bioscience (SKYE) position steady in Q1 2026 at 66 shares worth $39. The position accounts for ﹤0.01% of the portfolio, ranked #7374.

JP Morgan Chase first reported a position in SKYE in Q2 2024 and has held it in 6 quarters since. The position peaked at $120K in Q2 2024. 39 funds tracked by Wall St. Rank hold SKYE as of Q1 2026.

  • JP Morgan Chase held 66 shares of Skye Bioscience worth $39 as of Q1 2026.
  • JP Morgan Chase left its Skye Bioscience share count unchanged in Q1 2026.
  • Skye Bioscience made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7374 holding.
  • JP Morgan Chase first reported a position in Skye Bioscience in Q2 2024 and has held it in 6 quarters since.
  • JP Morgan Chase's Skye Bioscience position peaked at $120K in Q2 2024.
  • 39 funds tracked by Wall St. Rank held Skye Bioscience as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.